Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571792 · ClinicalTrials.gov registry record
Evaluation of Airway Gene Expression in COPD and Controlled Populations
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 42
- Enrollment target
NCT00571792: Clinical Trial study, sponsored by University of Nebraska.
NCT00571792 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00571792 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 42 participants
- Enrollment target
Study Summary
To explore potential proteins that may be used to develop novel therapies for COPD. This will be accomplished by acquiring material from the lower respiratory tract via endobronchial brushings.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2006-09-01 |
| Est. Completion | 2011-02-01 |
Why NCT00571792 stopped before completion
NCT00571792 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00571792 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00571792 about?
NCT00571792 is a clinical study titled "Evaluation of Airway Gene Expression in COPD and Controlled Populations". To explore potential proteins that may be used to develop novel therapies for COPD. This will be accomplished by acquiring material from the lower respiratory tract via endobronchial brushings.
What is the current status of trial NCT00571792?
This trial is currently terminated. The enrollment target is 42 participants. The study started on 2006-09-01. Estimated completion is 2011-02-01.
Who is sponsoring clinical trial NCT00571792?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI